<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02943174</url>
  </required_header>
  <id_info>
    <org_study_id>CINEICC-1-IAT</org_study_id>
    <secondary_id>SFRH/BD/101906/2014</secondary_id>
    <nct_id>NCT02943174</nct_id>
  </id_info>
  <brief_title>MIND Programme for Cancer Patients</brief_title>
  <official_title>MIND Programme for Cancer Patients: A Group Intervention Programme Based on Third Wave Psychotherapies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Coimbra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Coimbra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation aims to apply and test the feasibility of an acceptance, mindfulness and
      compassionate-based intervention structured for cancer patients. MIND programme for cancer
      thus comprises 8 weekly group sessions, lasting 1 and a half hour each, run in small groups
      at an Oncology Service at the Coimbra's University Hospital. For each week participants have
      assigned homework (e.g., mindfulness exercises). This programme mainly aims to increase
      participants' physical and psychosocial quality of life, and attenuate depressed mood and
      anxiety. Additionally, this study also intends to explore whether the reduction of depression
      and anxiety symptoms will promote better results in the medical treatments of the
      participants, and influence the course and prognosis of the illness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sample will include diagnosed cancer patients recruited at an Oncology Service at the
      Coimbra's University Hospital. Patients will be approached by their doctor to assess their
      level of interest in the investigation. Patients who demonstrate interest will go through a
      Screening interview conducted by a licensed psychologist that aims explain the structure and
      arms of the investigation, to collect demographic data, and whether the patient meets the
      inclusion criteria for the study. Patients who meet the inclusion criteria and demonstrate
      interest in participating in the study, will sign an informed consent. All ethical
      requirements for research with humans are guaranteed.

      Afterwards, participants will be randomized in two groups (experimental and control group).
      Both groups will maintain the medical treatment as usual (TAU). Additionally, the
      experimental group will enroll in the MIND programme for cancer patients, also provided by a
      licensed psychologist and a co-therapist.

      Both groups will concurrently complete a protocol of self-report measures and their medical
      data will be collected by the medical staff of the Hospital (to measure main three areas: a)
      psychological processes; b) quality of life and psychopathology; c) current medical status).
      These assessments will occur in four different times: before the start of the MIND programme
      M0), after the final session of the programme (M1), and 3 (M2) and 6 months (M4) after that.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in psychopathology (namely, depression and anxiety symptoms)</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by DASS-21</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Quality of Life</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the World Health Organization Quality of Life questionnaire (WHOQOL-BREF)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in experiential avoidance</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Acceptance and Action Questionnaire-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cognitive fusion related to chronic illness</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Cognitive Fusion Questionnaire - Chronic Illness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in mindfulness</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Mindful Attention Awareness Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body image</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Body Image Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Self-compassion and Fear from compassion from others</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Self-Compassion Scale and Fears of Compassion from Others</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Self-criticism</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Self-Compassion Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Chronic Ilness-related Shame</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Chronic Illness-related Shame Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Committed Action</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
    <description>Measured by the Committed Action Questionnaire-8</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in CA 15-3 and Biochemistry analyses</measure>
    <time_frame>From Baseline to 6-months follow-up</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>MIND Programme for cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MIND programme for cancer is a manualized acceptance, mindfulness and compassionate-based group intervention for cancer patients. It included 8 weekly group sessions, 2h hours each, run in small groups (ranging from 10 to 12 participants).
Participants in this group also receive cancer treatment as usually performed at the Coimbra University Hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as Usual (TAU)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cancer treatment as usually performed at the Coimbra University Hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MIND programme for cancer patients</intervention_name>
    <description>Psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for cancer patients Other: Cancer Treatment as Usual</description>
    <arm_group_label>MIND Programme for cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment as Usual (TAU)</intervention_name>
    <description>Standard personalized treatment of cancer</description>
    <arm_group_label>MIND Programme for cancer</arm_group_label>
    <arm_group_label>Treatment as Usual (TAU)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of cancer

        Exclusion Criteria:

          -  severe psychopathology

          -  difficulty in completing self-report measures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2016</study_first_submitted>
  <study_first_submitted_qc>October 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Coimbra</investigator_affiliation>
    <investigator_full_name>InÃªs A Trindade</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

